ASRS
SMMT icon

Arizona State Retirement System’s Summit Therapeutics SMMT Stock Holding History

Arizona State Retirement System’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-38,522
Closed -$159K – 2146
2024
Q1 		$159K Sell
38,522
-494
-1% -$1.96K ﹤0.01% 1990
2023
Q4 		$102K Sell
39,016
-714
-2% -$1.47K ﹤0.01% 2096
2023
Q3 		$74.3K Buy
39,730
+537
+1% +$1.02K ﹤0.01% 2112
2023
Q2 		$98.4K Buy
+39,193
New +$71.5K ﹤0.01% 2125

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Arizona State Retirement System's SMMT Position: Q2 2024 in Review

Arizona State Retirement System sold out of Summit Therapeutics (SMMT) in Q2 2024, closing a stake of 38,522 shares — an estimated $159K sold.

Arizona State Retirement System first reported a position in SMMT in Q2 2023 and held it in 4 quarters. The position peaked at $159K in Q1 2024. 123 funds tracked by Wall St. Rank hold SMMT as of Q2 2024.

  • Arizona State Retirement System reported no remaining Summit Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Arizona State Retirement System sold 38,522 Summit Therapeutics shares in Q2 2024, an estimated $159K.
  • Arizona State Retirement System first reported a position in Summit Therapeutics in Q2 2023 and held it in 4 quarters.
  • Arizona State Retirement System's Summit Therapeutics position peaked at $159K in Q1 2024.
  • 123 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2024.

Based on Arizona State Retirement System's 13F filing for Q2 2024, filed 5 Aug 2024.